You do not have to decide forever today. Suboxone and buprenorphine can be continued long term, and there is no required deadline for stopping. Many people do best by staying on medication because it protects their stability, recovery, and safety. Others may eventually decide to taper once life is more stable and the risk of relapse is lower. The best plan is individualized: based on your goals, your recovery, your support system, and your real-world overdose risk.

Yes, Suboxone works for many people with opioid use disorder. The strongest evidence shows that buprenorphine treatment helps people stay in care, reduces illicit opioid use, lowers overdose risk, and reduces mortality. But “working” does not mean it fixes every part of addiction or recovery. Suboxone helps quiet withdrawal, cravings, and overdose risk so patients can focus on the rest of recovery: health, relationships, work, mental health, support, and rebuilding daily life.

Suboxone does not automatically ruin your teeth, and dental risk should not be a reason to stop treatment suddenly. But dissolvable buprenorphine products can increase the risk of tooth decay, cavities, gum problems, or tooth loss in some patients. The best approach is to understand the risk, take prevention seriously, and know that there are practical steps that may help minimize or mitigate dental harm while continuing effective treatment. If you are worried about your teeth, talk with your treatment provider and dentist before making any medication changes.

MAT clinics do have a financial incentive to provide ongoing care, just like many other medical practices. The important question is whether the treatment is still medically appropriate, helping the patient, and being reassessed over time.

Long-term buprenorphine treatment is often safer and more effective than stopping medication too soon. But ethical care should never feel like autopilot. A good provider should be willing to discuss why medication is being continued, whether tapering might make sense someday, and how the plan fits the patient’s goals.

Suboxone diversion is real, and responsible addiction treatment clinics should take it seriously. But diversion is often more complicated than the idea that people are simply “selling their medication.” Many people who use non-prescribed Suboxone are trying to avoid withdrawal, reduce opioid use, taper themselves, or get through gaps in treatment access. At Shoreline, we use monitoring, structure, and clinical judgment to reduce risk while preserving the trust, dignity, and access that make treatment work.